One German company has decided to tackle the high-risk regulatory landscape for cannabinoid products in Europe’s largest economy head on with a new lobby group for CBD manufacturers and retailers. Sanity Group, a manufacturer of cannabinoid products based in Berlin, has joined forces with Canadian cannabis giant Aphria and Düsseldorf-based Cannacare Health to establish the